Clinical Scholar Application

Application Guidelines | Application Checklist

Timeline

• Applications are due by 5 p.m. on Feb. 16, 2024.
• Letters of award will be sent no later than April 15, 2024.
• Funding will commence on July 1, 2024.

Application Guidelines

• Applications should be submitted online no later than 5 p.m. on Feb. 16, 2024.
• Please use standard 11-point Arial font and half-inch margins throughout the application. Text should be single-spaced throughout. Pages should be consecutively numbered. Page 1 begins after the face page.
• All documents other than the face page should be rolled into a single PDF and uploaded as part of the electronic submission. PDF should follow the order of the Application Checklist.
• Applicants are strongly encouraged to consult a biostatistician in the Hollings Cancer Center Biostatistics Shared Resource (BSR) when developing the research design and methods of their proposals. For assistance, consult Hollings BSR biostatisticians (Dr. Betsy Hill, BSR: hille@musc.edu) or complete the Biostatistics Resource Request form. 

Application Checklist

• Face Page: Complete through online application portal.
• Personal Statement (1-page limit): In one or two paragraphs, describe your academic goals and proposed research as a Clinical Scholar; how you will lead in your specific discipline of oncology; and your approach for developing a cancer focused team, team science and projects that will help Hollings build a national reputation as a leader in your specific clinical/research discipline.
• Research Proposal 
  • Project Title
  • Project Summary (1-page limit): Abstract: Provide an executive summary that includes identification of the problem/challenge, overall goal, approach, and significance. Impact/Innovation: How will this project impact cancer research and/or clinical care in South Carolina?
  • Project Description (3-page limit): Suggested headings include:
    • Career Development Plan
    • Clinical metrics table including applicant’s current RVU metrics; clinical trial participation; and number of patient accruals to therapeutic/interventional and non-therapeutic clinical trials
    • Specific Aims
    • Background and Significance
    • Preliminary Data/Investigations
    • Experimental Design and Methods
    • Timeline of project completion and career plan
• NIH Biosketch
• Curriculum Vitae
• Letter of support from division chief and/or department chairman